
Phuong N. Huynh
Examiner (ID: 3827, Phone: (571)272-0846 , Office: P/1644 )
| Most Active Art Unit | 1644 |
| Art Unit(s) | 1641, 1644 |
| Total Applications | 2195 |
| Issued Applications | 1131 |
| Pending Applications | 251 |
| Abandoned Applications | 828 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5608444
[patent_doc_number] => 20060269960
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-30
[patent_title] => 'Isolated peptides corresponding to amino acid requirements of NY-ESO-1, which bind to MHC Class I and MHC Class II molecules, and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/499547
[patent_app_country] => US
[patent_app_date] => 2006-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9500
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20060269960.pdf
[firstpage_image] =>[orig_patent_app_number] => 11499547
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/499547 | Isolated nucleic acid molecules which encode immunogenic portions of NY-ESO-1 protein | Aug 3, 2006 | Issued |
Array
(
[id] => 5097325
[patent_doc_number] => 20070118934
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-24
[patent_title] => 'Chimeric toxin receptor proteins and chimeric toxin receptor proteins for treatment and prevention of anthrax'
[patent_app_type] => utility
[patent_app_number] => 11/498488
[patent_app_country] => US
[patent_app_date] => 2006-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 99
[patent_figures_cnt] => 99
[patent_no_of_words] => 40611
[patent_no_of_claims] => 84
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11498488
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/498488 | Chimeric toxin receptor proteins and chimeric toxin receptor proteins for treatment and prevention of anthrax | Aug 1, 2006 | Abandoned |
Array
(
[id] => 6639723
[patent_doc_number] => 20100036095
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-11
[patent_title] => 'Human CD59 mutants with modulated complement binding activity'
[patent_app_type] => utility
[patent_app_number] => 11/997650
[patent_app_country] => US
[patent_app_date] => 2006-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 24800
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0036/20100036095.pdf
[firstpage_image] =>[orig_patent_app_number] => 11997650
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/997650 | Human CD59 mutants with modulated complement binding activity | Jul 31, 2006 | Abandoned |
Array
(
[id] => 8629392
[patent_doc_number] => 08361461
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-01-29
[patent_title] => 'Anti-IGF-IR antibodies and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/989204
[patent_app_country] => US
[patent_app_date] => 2006-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 18
[patent_no_of_words] => 19544
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11989204
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/989204 | Anti-IGF-IR antibodies and uses thereof | Jul 20, 2006 | Issued |
Array
(
[id] => 5074814
[patent_doc_number] => 20070014789
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-18
[patent_title] => 'Humanized antibody conjugates and related methods, assays, reagents, and kits'
[patent_app_type] => utility
[patent_app_number] => 11/457537
[patent_app_country] => US
[patent_app_date] => 2006-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7714
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20070014789.pdf
[firstpage_image] =>[orig_patent_app_number] => 11457537
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/457537 | Humanized antibody conjugates and related methods, assays, reagents, and kits | Jul 13, 2006 | Abandoned |
Array
(
[id] => 5834238
[patent_doc_number] => 20060246068
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-02
[patent_title] => 'Polypeptides having a triggering NK activity and biological applications'
[patent_app_type] => utility
[patent_app_number] => 11/483991
[patent_app_country] => US
[patent_app_date] => 2006-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8051
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0246/20060246068.pdf
[firstpage_image] =>[orig_patent_app_number] => 11483991
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/483991 | Polypeptides having a triggering NK activity and biological applications | Jul 9, 2006 | Issued |
Array
(
[id] => 5331497
[patent_doc_number] => 20090111974
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-30
[patent_title] => 'Treatment of Liver Cirrhosis and Its Complications'
[patent_app_type] => utility
[patent_app_number] => 11/922702
[patent_app_country] => US
[patent_app_date] => 2006-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5142
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20090111974.pdf
[firstpage_image] =>[orig_patent_app_number] => 11922702
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/922702 | Treatment of liver cirrhosis and its complications | Jun 29, 2006 | Issued |
Array
(
[id] => 4982384
[patent_doc_number] => 20070086942
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-19
[patent_title] => 'Methods and compositions for generating bioactive assemblies of increased complexity and uses'
[patent_app_type] => utility
[patent_app_number] => 11/478021
[patent_app_country] => US
[patent_app_date] => 2006-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 19208
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20070086942.pdf
[firstpage_image] =>[orig_patent_app_number] => 11478021
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/478021 | Methods and compositions for generating bioactive assemblies of increased complexity and uses | Jun 28, 2006 | Issued |
Array
(
[id] => 4733401
[patent_doc_number] => 20080050380
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-28
[patent_title] => 'Glycoprotein VI and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/478074
[patent_app_country] => US
[patent_app_date] => 2006-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 44
[patent_no_of_words] => 72343
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0050/20080050380.pdf
[firstpage_image] =>[orig_patent_app_number] => 11478074
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/478074 | Glycoprotein VI and uses thereof | Jun 28, 2006 | Issued |
Array
(
[id] => 204335
[patent_doc_number] => 07629145
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-12-08
[patent_title] => 'VEGF-related protein'
[patent_app_type] => utility
[patent_app_number] => 11/427463
[patent_app_country] => US
[patent_app_date] => 2006-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 11
[patent_no_of_words] => 25893
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/629/07629145.pdf
[firstpage_image] =>[orig_patent_app_number] => 11427463
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/427463 | VEGF-related protein | Jun 28, 2006 | Issued |
Array
(
[id] => 5851122
[patent_doc_number] => 20060234313
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-19
[patent_title] => 'Modulation of angiogenesis through targeting of arginyl transferase (ATE1)'
[patent_app_type] => utility
[patent_app_number] => 11/473568
[patent_app_country] => US
[patent_app_date] => 2006-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7841
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20060234313.pdf
[firstpage_image] =>[orig_patent_app_number] => 11473568
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/473568 | Modulation of angiogenesis through targeting of arginyl transferase (ATE1) | Jun 21, 2006 | Issued |
Array
(
[id] => 6635951
[patent_doc_number] => 20100226924
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-09
[patent_title] => 'CHIMERIC POLY PEPTIDES AND THE THERAPEUTIC USE THEREOF AGAINST A FLAVIVIRIDAE INFECTION'
[patent_app_type] => utility
[patent_app_number] => 11/917907
[patent_app_country] => US
[patent_app_date] => 2006-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 7654
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20100226924.pdf
[firstpage_image] =>[orig_patent_app_number] => 11917907
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/917907 | Chimeric poly peptides and the therapeutic use thereof against a Flaviviridae infection | Jun 19, 2006 | Issued |
Array
(
[id] => 4932444
[patent_doc_number] => 20080003219
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-03
[patent_title] => 'DELIVERY OF AN OCULAR AGENT'
[patent_app_type] => utility
[patent_app_number] => 11/425194
[patent_app_country] => US
[patent_app_date] => 2006-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8385
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20080003219.pdf
[firstpage_image] =>[orig_patent_app_number] => 11425194
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/425194 | DELIVERY OF AN OCULAR AGENT | Jun 19, 2006 | Abandoned |
Array
(
[id] => 5699607
[patent_doc_number] => 20060216291
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-28
[patent_title] => 'Glycoprotein VI and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/447460
[patent_app_country] => US
[patent_app_date] => 2006-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 52667
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0216/20060216291.pdf
[firstpage_image] =>[orig_patent_app_number] => 11447460
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/447460 | Glycoprotein VI and uses thereof | Jun 5, 2006 | Abandoned |
Array
(
[id] => 5921444
[patent_doc_number] => 20060240036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-26
[patent_title] => 'I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1 and CD-95 induced apoptosis'
[patent_app_type] => utility
[patent_app_number] => 11/445311
[patent_app_country] => US
[patent_app_date] => 2006-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 22695
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0240/20060240036.pdf
[firstpage_image] =>[orig_patent_app_number] => 11445311
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/445311 | I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1 and CD-95 induced apoptosis | Jun 1, 2006 | Abandoned |
Array
(
[id] => 5360458
[patent_doc_number] => 20090035252
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-05
[patent_title] => 'Method of inducing a CTL response'
[patent_app_type] => utility
[patent_app_number] => 11/418497
[patent_app_country] => US
[patent_app_date] => 2006-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 26495
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20090035252.pdf
[firstpage_image] =>[orig_patent_app_number] => 11418497
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/418497 | Method of inducing a CTL response | May 2, 2006 | Abandoned |
Array
(
[id] => 8652649
[patent_doc_number] => 08372393
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-02-12
[patent_title] => 'Method of inducing a CTL response'
[patent_app_type] => utility
[patent_app_number] => 11/418397
[patent_app_country] => US
[patent_app_date] => 2006-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 14
[patent_no_of_words] => 26604
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11418397
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/418397 | Method of inducing a CTL response | May 2, 2006 | Issued |
Array
(
[id] => 5514256
[patent_doc_number] => 20090214562
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-27
[patent_title] => 'Combination of a beta-glucan and an egf receptor antagonist for the treatment of cancer and infection'
[patent_app_type] => utility
[patent_app_number] => 11/919927
[patent_app_country] => US
[patent_app_date] => 2006-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21380
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20090214562.pdf
[firstpage_image] =>[orig_patent_app_number] => 11919927
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/919927 | Combination of a beta-glucan and an egf receptor antagonist for the treatment of cancer and infection | May 1, 2006 | Abandoned |
Array
(
[id] => 5141364
[patent_doc_number] => 20070003580
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-04
[patent_title] => 'Anti-allergic pharmaceutical composition containing at least one allergen and at least one antihistamine compound'
[patent_app_type] => utility
[patent_app_number] => 11/413489
[patent_app_country] => US
[patent_app_date] => 2006-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11616
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20070003580.pdf
[firstpage_image] =>[orig_patent_app_number] => 11413489
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/413489 | Anti-allergic pharmaceutical composition containing at least one allergen and at least one antihistamine compound | Apr 27, 2006 | Issued |
Array
(
[id] => 5224694
[patent_doc_number] => 20070253960
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-01
[patent_title] => 'Pharmaceutical removal of vascular extensions from a degenerating disc'
[patent_app_type] => utility
[patent_app_number] => 11/413346
[patent_app_country] => US
[patent_app_date] => 2006-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 10566
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0253/20070253960.pdf
[firstpage_image] =>[orig_patent_app_number] => 11413346
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/413346 | Pharmaceutical removal of vascular extensions from a degenerating disc | Apr 27, 2006 | Abandoned |